Recombinant PTK7 (Cofetuzumab Biosimilar) antibody

Catalog No. ABIN7597597

The Humanized Chimeric anti-PTK7 (Cofetuzumab Biosimilar) antibody is suitable to detect PTK7 (Cofetuzumab Biosimilar) in samples from Human.

Quick Overview for Recombinant PTK7 (Cofetuzumab Biosimilar) antibody (ABIN7597597)

Target: PTK7 (Cofetuzumab Biosimilar)

Antibody Type: Recombinant Antibody

Reactivity: Human

Host: Humanized

Clonality: Chimeric

Conjugate: This PTK7 (Cofetuzumab Biosimilar) antibody is un-conjugated

Application: Please inquire

Grade: Research Grade

Product Details anti-PTK7 (Cofetuzumab Biosimilar) Antibody

Expression System: Mammalian cells

Purpose: Research Grade Cofetuzumab Biosimilar Antibody

Specificity: Protein-tyrosine kinase 7, Inactive tyrosine-protein kinase 7, CCK4, PTK7, Colon carcinoma kinase 4, Tyrosine-protein kinase-like 7, CCK-4, Pseudo tyrosine kinase receptor 7

Purification: Protein A or G purified from cell culture supernatant.

Purity: >95 % by SDS-PAGE.

Isotype: IgG1 kappa

Application Details

Restrictions: For Research Use only

Handling

Format: Liquid

Concentration: 1.11 mg/mL

Buffer: 0.01M PBS, pH 7.4.

Storage: 4 °C,-20 °C,-80 °C

Storage Comment: Use a manual defrost freezer and avoid repeated freeze-thaw cycles.Store at +4°C short term (1-2 weeks).Store at -20 °C 12 months. Store at -80°C long term.

Expiry Date: 12 months

Target Details for PTK7 (Cofetuzumab Biosimilar)

Target: PTK7 (Cofetuzumab Biosimilar)

Alternative Name: Cofetuzumab Biosimilar

Target Type: Biosimilar

Background: Protein-tyrosine kinase 7, Inactive tyrosine-protein kinase 7, CCK4, PTK7, Colon carcinoma kinase 4, Tyrosine-protein kinase-like 7, CCK-4, Pseudo tyrosine kinase receptor 7

UniProt: Q13308

CAS-No: 1869928-62-0